article Open AccessTop 10% cited
Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.
Chemical and Pharmaceutical Bulletin · 1986 · Vol. 34(7) · pp. 3025–3028
Aiko Morigiwa✉(Asahi Breweries (Japan))Katsuaki Kitabatake(Central Research Laboratories (United Kingdom))Yoshinori Fujimoto(Asahi Breweries (Japan))Nobuo Ikekawa(Asahi Breweries (Japan))
Abstract
The 70% MeOH extract of Ganoderma lucidum had an inhibitory effect on angiotensin converting enzyme activity, and from this extract, five new triterpenes, named ganoderal A, ganoderols A and B, and ganoderic acids K and S, were isolated. Their structures were determined on the basis of spectral evidence.
Fungal Biology and ApplicationsMedicinal plant effects and applicationsChemistryTerpenePolyporaceaeEnzymeInhibitory postsynaptic potentialGanodermaAngiotensin-converting enzymeGanoderma lucidumTriterpeneStereochemistry
MeSH terms
Angiotensin-Converting Enzyme InhibitorsAnimalsBasidiomycotaPolyporaceaeSwineTriterpenes
Citations
219
FWCI
2.84
field-weighted impact
References
0
Percentile
91%
vs. same field & year
Citations per year
Cited by
New Triterpene Aldehydes, Lucialdehydes A-C, from Ganoderma lucidum and Their Cytotoxicity against Murine and Human Tumor Cells.
Chemical and Pharmaceutical Bulletin · 2002 · 173 citations
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Frontiers in Pharmacology · 2020 · 407 citations
Ganoderma – A therapeutic fungal biofactory
Phytochemistry · 2006 · 853 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.